Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies
Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPubMed publications note reworded to indicate automatic filling from PubMed, and the page revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding lapse banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe new screenshot shows the same study detail page with only minor formatting/layout adjustments and no changes to core content such as study arms, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedMajor update: version bumped to v3.2.0 with a critical operating-status notice; previous version tag v3.1.0 removed.SummaryDifference1.0%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a Ubuntu-style versioning tag.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.